Momentum Stocks: XBiotech, Inc. (NASDAQ:XBIT), E-Commerce China Dangdang Inc. (NYSE:DANG), Raymond James Financial, Inc. (NYSE:RJF), PDL BioPharma, Inc. (NASDAQ:PDLI), Corning Inc. (NYSE:GLW)

XBiotech, Inc. (NASDAQ:XBIT) belongs to Healthcare sector. Its weekly performance is -4.74%. On last trading day company shares ended up $16.88. XBiotech, Inc. (NASDAQ:XBIT) distance from 50-day simple moving average (SMA50) is -13.68%. On 7 July, XBiotech, Inc. (NASDAQ:XBIT) announced publication of clinical results from an open label pilot study for its antibody therapy for treatment of Type 2 diabetes. The results are now available online as an “Article in Press” in the Journal of Diabetes and its Complications. The findings point towards a groundbreaking therapy for Type 2 diabetes by treating the disease rather than its symptoms.

E-Commerce China Dangdang Inc. (NYSE:DANG) shares fell -2.95% in last trading session and ended the day at $6.57. DANG Gross Margin is 17.70% and its return on assets is 0.60%. E-Commerce China Dangdang Inc. (NYSE:DANG) quarterly performance is -27.96%. E-Commerce China Dangdang Inc. (NYSE:DANG) announced that that its Board of Directors (the “Board”) has received a non-binding proposal letter, dated July 9, 2015, from Ms. Peggy Yu Yu, Chairwoman of the Board, and Mr. Guoqing Li, director and Chief Executive Officer of the Company (together, the “Buyer Group”), proposing a “going-private” transaction (the “Transaction”) to acquire all of the outstanding ordinary shares of the Company not already beneficially owned by the Buyer Group for $7.812 in cash per American depositary share (“ADS”), each representing five common shares.

On 10 July, Raymond James Financial, Inc. (NYSE:RJF) shares moved up 1.73% and was closed at $58.65. RJF EPS growth in last 5 year was 21.60%. Raymond James Financial, Inc. (NYSE:RJF) year to date (YTD) performance is 3.00%. Raymond James Financial, Inc. (NYSE:RJF) said that, its traditional brokerage unit has hired three financial advisers from UBS AG’s U.S. wealth-management arm, where they managed more than $300 million in client assets.

PDL BioPharma, Inc. (NASDAQ:PDLI) ended the last trading day at $6.30. Company weekly volatility is calculated as 2.85% and price to cash ratio as 2.47. PDL BioPharma, Inc. (NASDAQ:PDLI) showed a weekly performance of 2.77%. On 29 June, PDL BioPharma, Inc. (NASDAQ:PDLI) announced that it has entered into a credit agreement with CareView Communications, Inc. (OTCQB: CRVW) whereby PDL will provide CareView with up to $40 million of secured debt financing. CareView is an information technology provider to the healthcare industry focused on patient care monitoring.

Corning Inc. (NYSE:GLW) shares moved up 0.63% in last trading session and ended the day at $19.28. GLW Gross Margin is 41.80% and its return on assets is 9.30%. Corning Inc. (NYSE:GLW) quarterly performance is -13.52%. On 7 July, Corning Inc. (NYSE:GLW) has introduced the EDGE8 line of fiber optic cables for data centers and storage area networks (SANs).

Leave a Reply

Your email address will not be published. Required fields are marked *